Resolution of lung adenocarcinoma after discontinuation of ibrutinib

Por Khashab, Tamer, Loghavi, Sanam, Konoplev, Sergej N, Samaniego, Felipe
Publicado no BMJ Case Rep (2016)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

Por Shah, Shilpan, Loghavi, Sanam, Garcia-Manero, Guillermo, Khoury, Joseph D
Publicado em 2014

Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation

Por Khoury, Joseph D., Tashakori, Mehrnoosh, Yang, Hong, Loghavi, Sanam, Wang, Ying, Wang, Jing, Piya, Sujan, Borthakur, Gautam
Publicado no Cancers (Basel) (2020)

Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis—TAFRO syndrome

Por Jain, Preetesh, Verstovsek, Srdan, Loghavi, Sanam, Jorgensen, Jeffrey L., Patel, Keyur P., Estrov, Zeev, Fayad, Luis, Pemmaraju, Naveen
Publicado no Am J Hematol (2015)

DNMT3A, TET2 and JAK2 mutations in polycythemia vera (PV) following long- term remission of secondary acute myeloid leukemia (AML)

Por Jain, Preetesh, Verstovsek, Srdan, Wang, Wei, Loghavi, Sanam, Torres, Harrys A., Estrov, Zeev, Patel, Keyur P., Pemmaraju, Naveen
Publicado no Leuk Lymphoma (2015)

Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease

Por Graham, Kareem L., Zabel, Brian A., Loghavi, Sanam, Zuniga, Luis A., Ho, Peggy P., Sobel, Raymond A., Butcher, Eugene C.
Publicado em 2009

Immunophenotypic and Diagnostic Characterization of Angioimmunoblastic T-cell Lymphoma by Advanced Flow Cytometric Technology

Por Loghavi, Sanam, Wang, Sa A., Medeiros, L. Jeffrey, Jorgensen, Jeffrey L., Li, Xin, Xu-Monette, Zijun Y., Miranda, Roberto N., Young, Ken H.
Publicado no Leuk Lymphoma (2016)

Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm

Por Salem, Alireza, Loghavi, Sanam, Tang, Guilin, Huh, Yang O., Jabbour, Elias J., Kantarjian, Hagop, Wang, Wei, Hu, Shimin, Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Khoury, Joseph D.
Publicado no Am J Hematol (2017)

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup and residual...

Por Wang, Wei, Khoury, Joseph D., Miranda, Roberto N., Jorgensen, Jeffrey L., Xu, Jie, Loghavi, Sanam, Li, Shaoying, Pemmaraju, Naveen, Nguyen, Than, Medeiros, L. Jeffrey, Wang, Sa A.
Publicado no Haematologica (2020)

Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients

Por Loghavi, Sanam, Alayed, Khaled, Aladily, Tariq N., Zuo, Zhuang, Ng, Siok-Bian, Tang, Guilin, Hu, Shimin, Yin, C. Cameron, Miranda, Roberto N., Medeiros, L. Jeffrey, Khoury, Joseph D.
Publicado no J Hematol Oncol (2015)

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

Por Kanagal-Shamanna, Rashmi, Loghavi, Sanam, DiNardo, Courtney D., Medeiros, L. Jeffrey, Garcia-Manero, Guillermo, Jabbour, Elias, Routbort, Mark J., Luthra, Rajyalakshmi, Bueso-Ramos, Carlos E., Khoury, Joseph D.
Publicado no Haematologica (2017)

Intrauterine Growth Restriction Caused by Underlying Congenital Cytomegalovirus Infection

Por Pereira, Lenore, Petitt, Matthew, Fong, Alex, Tsuge, Mitsuru, Tabata, Takako, Fang-Hoover, June, Maidji, Ekaterina, Zydek, Martin, Zhou, Yan, Inoue, Naoki, Loghavi, Sanam, Pepkowitz, Samuel, Kauvar, Lawrence M., Ogunyemi, Dotun
Publicado em 2014

Early detection of transformation to BPDCN in a patient with MDS

Por Chamoun, Kamal, Loghavi, Sanam, Pemmaraju, Naveen, Konopleva, Marina, Kroll, Michael, Nguyen-Cao, Madeleine, Hornbaker, Marisa, DiNardo, Courtney D., Kadia, Tapan, Jorgensen, Jeffrey, Andreeff, Michael, Hu, Shimin, Benton, Christopher B.
Publicado no Exp Hematol Oncol (2018)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD

Por Sakhdari, Ali, Thakral, Beenu, Loghavi, Sanam, Kanagal‐Shamanna, Rashmi, Yin, C. Cameron, Zuo, Zhuang, Routbort, Mark J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Wang, Sa A., Patel, Keyur P., Ok, Chi Young
Publicado no Cancer Med (2019)

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated AML

Por Abbas, Hussein A., Ravandi, Farhad, Loghavi, Sanam, Patel, Keyur P., Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Takahashi, Koichi, Cortes, Jorge, Issa, Ghayas C., Konopleva, Marina, Kantarjian, Hagop M., Short, Nicholas J.
Publicado no Am J Hematol (2019)

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

Por Loghavi, Sanam, Zuo, Zhuang, Ravandi, Farhad, Kantarjian, Hagop M, Bueso-Ramos, Carlos, Zhang, Liping, Singh, Rajesh R, Patel, Keyur P, Medeiros, L Jeffrey, Stingo, Francesco, Routbort, Mark, Cortes, Jorge, Luthra, Rajyalakshmi, Khoury, Joseph D
Publicado em 2014

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors

Por Mehrotra, Meenakshi, Singh, Rajesh R., Loghavi, Sanam, Duose, Dzifa Yawa, Barkoh, Bedia A., Behrens, Carmen, Patel, Keyur P., Routbort, Mark J., Kopetz, Scott, Broaddus, Russell R., Medeiros, L. Jeffrey, Wistuba, Ignacio I., Luthra, Rajyalakshmi
Publicado no Oncotarget (2017)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

Por Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicado no Front Oncol (2020)

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

Por Quesada, Andrés E., Hu, Zhihong, Routbort, Mark J., Patel, Keyur P., Luthra, Rajyalakshmi, Loghavi, Sanam, Zuo, Zhuang, Yin, C. Cameron, Kanagal-Shamanna, Rashmi, Wang, Sa A., Jorgensen, Jeffrey L., Medeiros, L. Jeffrey, Ok, Chi Young
Publicado no Oncotarget (2018)

Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features

Por Shuai, Wen, Lin, Pei, Strati, Paolo, Patel, Keyur P., Routbort, Mark J., Hu, Shimin, Wei, Peng, Khoury, Joseph D., You, M. James, Loghavi, Sanam, Tang, Zhenya, Fang, Hong, Thakral, Beenu, Medeiros, L. Jeffrey, Wang, Wei
Publicado no Blood Cancer J (2020)